Advanced Pneumatic Compression Device for Lymphedema
Trial Summary
What is the purpose of this trial?
This trial compares the effectiveness of an air pressure device (APCD) to standard treatment in reducing swelling and improving quality of life for head and neck cancer survivors. The device works by gently massaging the swollen areas to help move excess fluid out of the tissues.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the Advanced Pneumatic Compression Device treatment for lymphedema?
Research shows that advanced pneumatic compression devices (APCDs) can effectively reduce arm swelling and tissue water in patients with lymphedema after breast cancer treatment. Additionally, APCDs have been found to improve the quality of life for patients with lower-extremity lymphedema by mimicking a functional drainage system.12345
Is the Advanced Pneumatic Compression Device safe for humans?
How is the Advanced Pneumatic Compression Device treatment different from other treatments for lymphedema?
The Advanced Pneumatic Compression Device (APCD) is unique because it mimics a functional drainage system by targeting lymphatic beds, offering a novel way to manage lymphedema. It provides focused treatment with different cycles and is used as part of a self-care regimen, although it requires the patient to be immobile during use.12348
Research Team
Barbara Murphy, MD
Principal Investigator
Vanderbilt University Medical Center
Sheila Ridner, RN, PhD
Principal Investigator
Vanderbilt University
Eligibility Criteria
This trial is for English-speaking adults over 18 who've finished cancer treatment with no active cancer, have head and neck lymphedema diagnosed, and experience related symptoms. It's not for those previously treated for this condition, with acute facial infections, carotid sinus hypersensitivity, recent severe carotid artery disease events or internal jugular venous thrombosis.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive self-administered APCD therapy or Usual Care for head and neck lymphedema
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Advanced Pneumatic Compression Device
- Usual Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tactile Medical
Lead Sponsor
Vanderbilt University Medical Center
Collaborator